New Protein Vector ApE1 for Targeted Delivery of Anticancer Drugs. (9th May 2012)

• Record Type: Journal Article
• Authors: Pozdniakova, N. V.; Gorokhovets, N. V.; Gukasova, N. V.; Bereznikova, A. V.; Severin, E. S.
• Other Names: Mehta Kapil Academic Editor.
• Is Part Of: Journal of biomedicine and biotechnology. Volume 2012(2012)
• Publication Date: 2012-05-09
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Medicine; Biology; Biotechnology; Médecine; Biologie; Biotechnologie; Biology; Biotechnology; Medicine; Biotechnology; Biomedicine; Electronic journals; Periodical; Periodicals; Electronic journals; 610
• DOI: 10.1155/2012/469756
• Languages: English
• ISSNs: 1110-7243

Abstract

Abstract : A new chimeric gene ApE1 encoding the receptor-binding domain of the human alpha -fetoprotein fused to a sequence of 22 glutamic acid residues was constructed. A new bacterial producer strain E. coli SHExT7 ApE1 was selected for ApE1 production in a soluble state. A simplified method was developed to purify ApE1 from bacterial biomass. It was shown that the new vector protein selectively interacts with AFP receptors on the tumor cell surface and can be efficiently accumulated in tumor cells. In addition, ApE1 was shown to be stable in storage and during its chemical modification. An increased number of carboxyl groups in the molecule allows the production of cytotoxic compound conjugates with higher drug-loading capacity and enhanced tumor targeting potential.